From Methods to Knowledge Space: An AQbD - Driven Critical Review of Trelagliptin HPLC Methods (2015 – 2025)
Future Journal of Pharmaceuticals and Health Sciences · 28.04.2026 · 6 (2) · 91-107
DOI: 10.26452/fjphs.v6i2.566 ↗Kurz gefasst
Fachartikel in der Zeitschrift Future Journal of Pharmaceuticals and Health Sciences, online erschienen am 28.04.2026. Verfasst von {"name":"Rallapalli Venkata Swathi","email":"swathirallapalli212@gmail.com","aff und 4 weiteren Autor:innen.
Abstract (Originalsprache)
The present review systematically translates the analytical landscape of Trelagliptin HPLC/UPLC methods reported between 2015 and 2025 into an Analytical Quality by Design driven framework, facilitating the transition from method - centric development to a structured knowledge space. A curated dataset of 18 methods was critically evaluated to quantify method diversity, applicability, and analytical performance across assay, stabilit y - indicating, related substances, impurity characterization, bioanalytical, an d chiral domains. Assay methods constituted ~40% of the reported approaches, primarily applied for routine tablet analysis, exhibiting linearity within 1 – 100 μg/mL and precision below 2.0% RSD. Stability - indicating methods (~25%) demonstrated effective separation of Trelagliptin from degradation products under stress conditions, with resolution values exceeding 2.0 and degradation levels typically within 5 – 20%. Related substances and impurity profiling methods (~15%) enabled trace - level detection (LOD: 0.01 – 0.05 μg/mL). Bioanalyt ical methods (~15%), predominantly LC – MS/MS - based, achieved high sensitivity with LLOQ in the low ng/mL range, while chiral methods were limited (~5%), focusing on enantiomeric separation using specialized stationary phases. Key Critical Method Variables (CMVs), organic composition (40 – 70%), mobile phase pH (2.5 – 4.5), flow rate (0.8 – 1.2 mL/min), and C18 stationary phases, significantly influenced Critical Quality Attributes (CQAs) such as retention time, peak symmetry (≤1.5), the oretical plates (>3000), and resolution (≥2.0). Integration of CMV – CQA relationships enabled the construction of a comprehensive knowledge space, further translated into a multidimensional design space using DoE principles. This AQbD framework establishes ICH Q14 - aligned Analytical Target Profiles, providing a robust, knowledge - driven pathway for method development, optimization, and lifecycle management of Trelagliptin analytical procedures.
Zitieren
APA
Swathi","email":"swathirallapalli212@gmail.com","aff, N. V., Eri","email":"swathirallapalli212@gmail.com","affiliat, N. K., Susmitha","email":"swathirallapalli212@gmail.com","affiliati, N., Sree","email":"swathirallapalli212@gmail.com","affilia, N. P., & Swarnalatha","email":"swathirallapalli212@gmail.com","affili, N. (2026). From Methods to Knowledge Space: An AQbD - Driven Critical Review of Trelagliptin HPLC Methods (2015 – 2025). Future Journal of Pharmaceuticals and Health Sciences, 6(2), 91-107. https://doi.org/10.26452/fjphs.v6i2.566
Vancouver
Swathi","email":"swathirallapalli212@gmail.com","aff NV, Eri","email":"swathirallapalli212@gmail.com","affiliat NK, Susmitha","email":"swathirallapalli212@gmail.com","affiliati N, Sree","email":"swathirallapalli212@gmail.com","affilia NP, Swarnalatha","email":"swathirallapalli212@gmail.com","affili N. From Methods to Knowledge Space: An AQbD - Driven Critical Review of Trelagliptin HPLC Methods (2015 – 2025). Future Journal of Pharmaceuticals and Health Sciences. 2026;6(2):91-107. doi:10.26452/fjphs.v6i2.566
BibTeX
@article{Swathiemailswathirallapalligmailcomaff2026,
author = {Swathi","email":"swathirallapalli212@gmail.com","aff, "name":"Rallapalli Venkata and Eri","email":"swathirallapalli212@gmail.com","affiliat, "name":"Gireesh Kumar and Susmitha","email":"swathirallapalli212@gmail.com","affiliati, "name":"Aggarapu and Sree","email":"swathirallapalli212@gmail.com","affilia, "name":"Yellamraju Padma and Swarnalatha","email":"swathirallapalli212@gmail.com","affili, "name":"Dugasani},
title = {From Methods to Knowledge Space: An AQbD - Driven Critical Review of Trelagliptin HPLC Methods (2015 – 2025)},
journal = {Future Journal of Pharmaceuticals and Health Sciences},
year = {2026},
volume = {6},
number = {2},
pages = {91--107},
doi = {10.26452/fjphs.v6i2.566}
}
EUVIMED